VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+2.93%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$182M
AUM Growth
-$9.72M
(-5.1%)
Cap. Flow
-$9.36M
Cap. Flow
% of AUM
-5.15%
Top 10 Holdings %
Top 10 Hldgs %
6.2%
Holding
508
New
65
Increased
160
Reduced
215
Closed
68
Top Buys
| 1 |
Dow Inc
DOW
|
$1.16M |
| 2 |
Hershey
HSY
|
$1.04M |
| 3 |
Copart
CPRT
|
$1.03M |
| 4 |
lululemon athletica
LULU
|
$1.02M |
| 5 |
Progressive
PGR
|
$999K |
Top Sells
| 1 |
Lennar Class A
LEN
|
$952K |
| 2 |
TJX Companies
TJX
|
$909K |
| 3 |
Ameriprise Financial
AMP
|
$902K |
| 4 |
Abbott
ABT
|
$892K |
| 5 |
Home Depot
HD
|
$885K |
Sector Composition
| 1 | Healthcare | 25.65% |
| 2 | Financials | 14.09% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.21% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
BlackRock TCP Capital
TCPC
$611M
| $281K | 0.15% |
27,316
+191
| +0.7% | +$1.97K |
|
252
American Electric Power
AEP
$58.1B
| $281K | 0.15% |
+3,083
| New | +$281K |
|
253
Enanta Pharmaceuticals
ENTA
$190M
| $280K | 0.15% |
6,924
+124
| +2% | +$5.02K |
|
254
Copel
ELP
$6.65B
| $279K | 0.15% |
51,900
-29,230
| -36% | -$157K |
|
255
Camden Property Trust
CPT
$11.8B
| $279K | 0.15% |
+2,657
| New | +$279K |
|
256
ADMA Biologics
ADMA
$4.04B
| $278K | 0.15% |
83,925
+1,486
| +2% | +$4.92K |
|
|
EFT
257
Eaton Vance Floating-Rate Income Trust
EFT
$321M
| $278K | 0.15% |
24,129
-1,342
| -5% | -$15.4K |
|
258
Amgen
AMGN
$151B
| $278K | 0.15% |
1,148
+32
| +3% | +$7.74K |
|
|
ICPT
259
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $277K | 0.15% |
20,618
+367
| +2% | +$4.93K |
|
260
Fidus Investment
FDUS
$757M
| $276K | 0.15% |
14,483
+1,850
| +15% | +$35.3K |
|
261
BioMarin Pharmaceuticals
BMRN
$10.9B
| $276K | 0.15% |
2,839
+47
| +2% | +$4.57K |
|
262
Eversource Energy
ES
$23.5B
| $275K | 0.15% |
+3,510
| New | +$275K |
|
263
Amicus Therapeutics
FOLD
$2.47B
| $274K | 0.15% |
24,739
+438
| +2% | +$4.86K |
|
264
Ascendis Pharma
ASND
$12B
| $272K | 0.15% |
2,536
+45
| +2% | +$4.83K |
|
265
Ultragenyx Pharmaceutical
RARE
$3.01B
| $272K | 0.15% |
6,777
+122
| +2% | +$4.89K |
|
266
Kimbell Royalty Partners
KRP
$1.28B
| $268K | 0.15% |
+17,629
| New | +$268K |
|
267
Black Hills Corp
BKH
$4.34B
| $266K | 0.15% |
+4,222
| New | +$266K |
|
268
PennantPark Floating Rate Capital
PFLT
$1.02B
| $264K | 0.15% |
24,920
-10,401
| -29% | -$110K |
|
269
Alnylam Pharmaceuticals
ALNY
$59.4B
| $264K | 0.15% |
1,317
+24
| +2% | +$4.81K |
|
270
ICL Group
ICL
$7.86B
| $263K | 0.14% |
+38,638
| New | +$263K |
|
271
Insmed
INSM
$30.1B
| $263K | 0.14% |
15,406
+271
| +2% | +$4.62K |
|
272
Neurocrine Biosciences
NBIX
$13.9B
| $262K | 0.14% |
2,585
+48
| +2% | +$4.86K |
|
|
RETA
273
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $261K | 0.14% |
2,874
-1,101
| -28% | -$100K |
|
274
Ironwood Pharmaceuticals
IRWD
$179M
| $261K | 0.14% |
24,838
+439
| +2% | +$4.62K |
|
275
Viper Energy
VNOM
$6.59B
| $260K | 0.14% |
+9,273
| New | +$260K |
|